Mustafa Gökhan ERTOSUN, Gamze TANRIÖVER, Sayra DİLMAÇ, Suray PEHLİVANOĞLU, Osman Nidai ÖZEŞ

AKT-mediated phosphorylation of TWIST1 is essential for breast cancer cell metastasis

Previously, it was shown that human TWIST1 (basic helix-loop-helix (b-HLH) is phosphorylated by Akt kinase at S42, T121, and S123. To show in vivo effect of these phosphorylations, we created mouse TWIST1 expression vector and converted the codons of S42, T125, and S127 to unphosphorylatable alanine and phosphorylation mimicking Glutamic acid. We hypothesized that alanine mutants would inhibit the metastatic ability of 4T1 cells while glutamic acid mutants would convert nonmetastatic 67NR cells into metastatic phenotype. To confirm this hypothesis, we created metastatic 4T1 and nonmetastatic 67NR cells expressing alanine mutants and glutamic acid mutants mouse TWIST1, respectively. Then, we injected 1 x 10(6) 67NR and 1 x 10(5) 4T1 cells overexpressing mutants of TWIST1 into the breast tissue of BALB/c mice. At the end of the 4th week, we sacrificed the animals, determined the numbers of tumors at lungs and liver. Although 67NR cells overexpressing wild-type TWIST1 did not show any metastasis, cells overexpressing S42E and T125E mutants showed 15-30 macroscopic metastasis to liver and lungs. Parallel to this, 4T1 cells expressing S42A and T125A mutants of TWIST1 showed no macroscopic metastasis. Our results indicate that phosphorylation of S42 and T125 by AKT is essential for TWIST1-mediated tumor growth and metastasis.

PDF

___

Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C et al. (2006). N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of TWIST1. Cancer Research 66: 3365-3369.
Bialek P, Kern B, Yang X, Schrock M, Sosic D et al. (2004). A twist code determines the onset of osteoblast differentiation. Developmental Cell 6: 423-435.
Chen ZF, Behringer RR (1995). Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & Development 9: 686-699.
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD et al. (2007). Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Research 67: 1979-1987.
Cheng GZ, Zhang W, Wang LH (2008). Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Research 68: 957-960.
Connerney J, Andreeva V, Leshem Y, Muentener C, Mercado MA et al. (2006). TWIST1 dimer selection regulates cranial suture patterning and fusion. Developmental Dynamics 235: 1345- 1357.
el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P et al. (1997). Mutations of the TWIST gene in the SaethreChotzen syndrome. Nature Genetics 15: 42-46.
Elias MC, Tozer KR, Silber JR, Mikheeva S, Deng M et al. (2005). TWIST is expressed in human gliomas and promotes invasion. Neoplasia 7: 824-837.
Funato N, Ohtani K, Ohyama K, Kuroda T, Nakamura M (2001). Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Moleculer Cell Biology 21: 7416-7428.
Gong XQ, Li L. (2002). Dermo-1, a multifunctional basic helixloop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. Journal of Biological Chemistry 277: 12310-12317.
Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N et al. (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nature Genetics 15: 36- 41.
Kingston RE, Chen CA, Okayama H. (2003). Calcium phosphate transfection. Current Protocols in Cell Biology 20: 20.3
Kyo S, Sakaguchi J, Ohno S, Mizumoto Y, Maida Y et al. (2006). High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Human Pathology 37: 431-438.
Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK et al. (2006). Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research 12: 5369-5376.
Mironchik Y, Winnard PT, Jr., Vesuna F, Kato Y, Wildes F et al. (2005). Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Research 65: 10801-10809.
Qin Q, Xu Y, He T, Qin C, Xu J (2012). Normal and disease-related biological functions of TWIST1 and underlying molecular mechanisms. Cell Research 22: 90-106.
Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ (2000). Integration of FGF and TWIST in calvarial bone and suture development. Development 127: 1845-1855.
Singh S MI, Handa D, Ghert M (2014). The role of TWIST in angiogenesis and cell migration in giant cell tumor of bone. Advances in Biology 2014: 1-8.
Wang D, Rai B, Qi F, Liu T, Wang J et al. (2018). Influence of the Twist gene on the invasion and metastasis of colon cancer. Oncology Reports 39: 31-44.
Xu Y, Qin L, Sun T, Wu H, He T et al. (2017). TWIST1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Oncogene 36: 1157-66.
Xu Y, Xu Y, Liao L, Zhou N, Theissen SM et al. (2013). Inducible knockout of TWIST1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting TWIST1 as a preferential cancer target. American Journal of Pathology 183: 1281-1292.
Xue G, Restuccia DF, Lan Q, Hynx D, Dirnhofer S et al. (2012). Akt/ PKB-mediated phosphorylation of TWIST1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-beta signaling axes. Cancer Discovery 2: 248-259.
Yan-Qi Z, Xue-Yan G, Shuang H, Yu C, Fu-Lin G et al. (2007). Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer. Pathology, 39: 470- 475.
Yousfi M, Lasmoles F, Marie PJ (2002). TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts. Biochemical and Biophysical Research Communications, 297: 641-644.